Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$6,844,792
+$41,069 QoQ
Shares Held
18,902
-2.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#689
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEIZERT CAPITAL PARTNERS, LLC holds $92,983,054 across 6 Drug Manufacturers - General names. AMGN ranks #3 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
162,741 | $41,331,331 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
667,883 | $38,483,418 | |
| 3 | AMGN |
Amgen Inc
This page
|
18,902 | $6,844,792 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
37,822 | $4,778,431 | |
| 5 | ABBV |
AbbVie Inc.
|
3,980 | $1,001,527 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,230 | $543,555 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,844,792 | 18,902 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $6,803,723 | 19,337 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $7,160,888 | 21,878 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $6,681,931 | 23,678 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $45,493,360 | 162,936 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $54,485,733 | 174,886 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $49,589,887 | 190,262 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $62,135,620 | 192,842 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $59,815,115 | 191,439 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $58,960,575 | 207,374 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $58,979,871 | 204,777 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $56,844,352 | 211,506 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $46,310,707 | 208,588 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $49,263,331 | 203,778 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $49,777,896 | 189,529 | Shares | Sole | 2023-03-28 | |
| 2022-09-30 | $47,061,716 | 208,792 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $50,681,336 | 208,308 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $49,259,459 | 203,703 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $45,748,774 | 203,355 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $42,562,748 | 200,154 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $47,659,950 | 195,528 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $39,641,902 | 159,326 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $32,118,214 | 139,693 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $34,775,187 | 136,824 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $34,237,437 | 145,160 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $30,927,677 | 152,556 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||